PCPP (poly[di(carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune responses in mice.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Vaccine

• Publication date

  2010-12-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2010.09.080PMID 21036133
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of environmental factors on hydrolytic degradation of water-soluble polyphosphazene polyelectrolyte in aqueous solutions.

  2010cited by this paper
• Enhancement of immunoprotective effect of CpG-ODN by formulation with polyphosphazenes against E. coli septicemia in neonatal chickens.

  2009cited by this paper
• Strategies to link innate and adaptive immunity when designing vaccine adjuvants.

  2009cited by this paper
• Induction of mucosal and systemic humoral immune responses in murine system by intranasal immunization with peptide antigens of P. vivax and CpG oligodeoxynucleotide (ODN) in microparticle delivery.

  2009cited by this paper
• Intranasal administration of peptide antigens of HIV with mucosal adjuvant CpG ODN coentrapped in microparticles enhances the mucosal and systemic immune responses.

  2009cited by this paper
• Innovative strategies for co-delivering antigens and CpG oligonucleotides.

  2009cited by this paper
• Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles.

  2009cited by this paper
• Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.

  2008cited by this paper
• Co‐administration of carcinoembryonic antigen and HIV TAT fusion protein with CpG‐oligodeoxynucleotide induces potent antitumor immunity

  2008cited by this paper
• Intranasal immunization of mice with a formalin-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection.

  2008cited by this paper
• Molecular and cellular signatures of human vaccine adjuvants

  2008cited by this paper
• Coencapsulation of CpG Oligodeoxynucleotides with Recombinant Leishmania major Stress-Inducible Protein 1 in Liposome Enhances Immune Response and Protection against Leishmaniasis in Immunized BALB/c Mice

  2008cited by this paper
• Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders.

  2008cited by this paper
• Targeting CpG Oligonucleotides to the Lymph Node by Nanoparticles Elicits Efficient Antitumoral Immunity1

  2008cited by this paper
• Whole body and tissue imaging of the butyrylcholinesterase knockout mouse injected with near infrared dye labeled butyrylcholinesterase.

  2008cited by this paper
• The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles.

  2008cited by this paper
• Alum adjuvanticity: Unraveling a century old mystery

  2008cited by this paper
• Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.

  2008cited by this paper
• Antigen co‐encapsulated with adjuvants efficiently drive protective T cell immunity

  2007cited by this paper
• Potent Antigen-specific Immune Responses Stimulated by Codelivery of CpG ODN and Antigens in Degradable Microparticles

  2007cited by this paper
• Enhancement of functional antibody responses to AMA1-C1/Alhydrogel, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide.

  2006cited by this paper
• Synthesis, properties, and biological activity of poly[di(sodium carboxylatoethylphenoxy)phosphazene].

  2006cited by this paper
• Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity.

  2005cited by this paper
• Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis.

  2005cited by this paper
• Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles.

  2005cited by this paper
• Protective CD8 T Cell Immunity Triggered by CpG-Protein Conjugates Competes with the Efficacy of Live Vaccines1

  2005cited by this paper
• CpG motifs are efficient adjuvants for DNA cancer vaccines.

  2004cited by this paper
• Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

  2004cited by this paper
• Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes.

  2004cited by this paper
• Synthesis and biologically relevant properties of polyphosphazene polyacids.

  2004cited by this paper
• Regulation of Phagosome Maturation by Signals from Toll-Like Receptors

  2004cited by this paper
• Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.

  2004cited by this paper
• Vaccine adjuvants: Current state and future trends

  2004cited by this paper
• Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes.

  2003cited by this paper
• CpG DNA: Trigger of Sepsis, Mediator of Protection, or Both?

  2003cited by this paper
• Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.

  2002cited by this paper
• Evaluation of Cholera Vaccines Formulated with Toxin-Coregulated Pilin Peptide Plus Polymer Adjuvant in Mice

  2001cited by this paper
• CpG oligodeoxynucleotides enhance monoclonal antibody therapy of a murine lymphoma.

  2000cited by this paper
• Effects of different adjuvants on rotavirus antibody responses and protection in mice following intramuscular immunization with inactivated rotavirus.

  1999cited by this paper
• CpG-Containing Oligonucleotides Are Efficient Adjuvants for Induction of Protective Antiviral Immune Responses with T-Cell Peptide Vaccines

  1999cited by this paper
• CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.

  1999cited by this paper
• CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.

  1998cited by this paper
• Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions.

  1998cited by this paper
• Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine.

  1998cited by this paper
• Protein release from polyphosphazene matrices.

  1998cited by this paper
• Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization.

  1997cited by this paper
• Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery.

  1995cited by this paper
• Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.

  1994cited by this paper
• Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies

  1991cited by this paper
• B-cell memory is short-lived in the absence of antigen.

  1991cited by this paper
• Macrophage Activation for Antitumour Function by Muramyl Dipeptide‐protein Conjugates

  1990cited by this paper
• Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response.

  1989cited by this paper
• T cell memory is short-lived in the absence of antigen

  1988cited by this paper

• Microparticulated Polygonatum sibiricum polysaccharide shows potent vaccine adjuvant effect.

  2024cites this paper
• Biodegradable Polyphosphazenes for Biomedical Applications

  2023cites this paper
• Lipid Microparticles Show Similar Efficacy With Lipid Nanoparticles in Delivering mRNA and Preventing Cancer

  2022cites this paper
• Immunogenic evaluation of multi-epitope peptide-loaded PCPP microparticles as a vaccine candidate against Toxoplasma Gondii.

  2022cites this paper
• Principles of Vaccinology and Vaccine Immune Response

  2021cites this paper
• Biocompatibility of Poly[di(carboxylatophenoxy)-phosphazene] Polymer: In Vitro Cytotoxicity in Cell Culture

  2021cites this paper
• Polyphosphazenes as Adjuvants for Animal Vaccines and Other Medical Applications

  2021cites this paper
• Crosslinking Strategies to Develop Hydrogels for Biomedical Applications

  2021cites this paper
• Polyphosphazenes for the delivery of biopharmaceuticals

  2020cites this paper
• Polyphosphazene immunoadjuvants: Historical perspective and recent advances.

  2020cites this paper
• Proof of Concept for Prevention of Natural Colonization by Oral Needle-Free Administration of a Microparticle Vaccine

  2020influential citation
• Synthetic Cationic Peptide IDR-1002 and Human Cathelicidin LL37 Modulate the Cell Innate Response but Differentially Impact PRRSV Replication in vitro

  2019cites this paper
• INNATE IMMUNE RESPONSES ACTIVATED BY THE ADJUVANT POLY [DI (SODIUM CARBOXYLATOETHYLPHENOXY)PHOSPHAZENE](PCEP) IN PIGS

  2019influential citation
• Solution radical polymerization

  2019cites this paper
• Biodegradable polymers for modern vaccine development

  2019cites this paper
• Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral titres in pigs.

  2018cites this paper
• Effective intracellular delivery and Th1 immune response induced by ovalbumin loaded in pH-responsive polyphosphazene polymersomes.

  2018cites this paper
• Recent advances in experimental polyphosphazene adjuvants and their mechanisms of action

  2018cites this paper
• Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice.

  2017cites this paper
• Cell-Mediated and Humoral Immune Responses to Bordetella pertussis Inactivated Whole-Cells Encapsulated Alginate Microspheres as a New Vaccine Candidate.

  2017cites this paper
• Interpolyelectrolyte complexes of lysozyme with short poly[di(carboxylatophenoxy)phosphazene]. Binding energetics and protein conformational stability

  2017cites this paper
• Carboxyl derivatives of phosphazenes

  2017cites this paper
• Response of immune response genes to adjuvants poly [di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP), CpG oligodeoxynucleotide and emulsigen at intradermal injection site in pigs.

  2016cites this paper
• Oral antigen exposure in newborn piglets circumvents induction of oral tolerance in response to intraperitoneal vaccination in later life

  2015cites this paper
• Adjuvants for veterinary vaccines--types and modes of action.

  2015cites this paper
• Polarized immune responses modulated by layered double hydroxides nanoparticle conjugated with CpG.

  2014cites this paper
• Vaccine Potentiation by Combination Adjuvants

  2014cites this paper
• Nanodisco Balls: Control over Surface versus Core Loading of Diagnostically Active Nanocrystals into Polymer Nanoparticles

  2014cites this paper
• Evidence for a common mucosal immune system in the pig☆

  2014cites this paper
• Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies.

  2013cites this paper
• Cellular and molecular mechanisms of action of the novel adjuvant polyphosphazene

  2013cites this paper
• IMPACT OF NONSTRUCTURAL HEPATITIS C VIRUS ANTIGENS AND TOLL-LIKE RECEPTOR AGONISTS ON DENDRITIC CELL IMMUNOGENICITY

  2013cites this paper
• Carrier molecules for use in veterinary vaccines.

  2013cites this paper
• Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles.

  2012cites this paper
• The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development

  2012cites this paper
• Do we know the Th1/Th2/Th17 determinants of vaccine response?

  2012cites this paper
• Low Dose Antigen Exposure for a Finite Period in Newborn Rats Prevents Induction of Mucosal Tolerance

  2012cites this paper
• Bacterial flagellin- a novel adjuvant for vaccine strategies

  2011cites this paper
• Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis.

  2011cites this paper
• Selection of Adjuvants for Enhanced Vaccine Potency

  2011cites this paper